Aurora Cannabis Inc. (TSX:ACB) Acquires Another Company: Why This Is Good News for Investors

Aurora Cannabis Inc (TSX:ACB) continues to wheel and deal as it looks to expand its reach and capabilities in the industry.

| More on:

Aurora Cannabis Inc. (TSX:ACB) is going to purchase yet another company. In a much smaller acquisition than its $3.2 billion purchase of MedReleaf Corp. (TSX:LEAF), Aurora is going to acquire Anandia Laboratories for a price tag of $115 million. The Vancouver-based company will provide Aurora with valuable research and development and testing services.

Not a lot of green on the balance sheet

The deal to purchase Anandia is an all-stock acquisition, as Aurora has a limited supply of cash on its balance sheet. In the company’s most recent quarter, it had just $231 million in cash and equivalents, so this acquisition, small as it may be, would have depleted about half that amount.

While the all-stock deal makes it easy to arrange payment, investors will feel the impact of more dilution, as the company will once again issue more shares in order to fund the transaction.

Positioning itself for strong growth ahead

The acquisition of MedReleaf and Anandia tell me that Aurora is wisely trying to focus on the opportunities that exist in medical marijuana as well as the potential that exists in the recreational pot market.

While recreational marijuana is certainly all the rage this year, the more significant growth opportunities may actually lie in the medical market. Many studies have found marijuana to be effective for pain relief and in treating various types of ailments.

The challenge for cannabis companies is proving that there are some very significant advantages to using marijuana for medical purposes. It hasn’t helped that studies on cannabis are limited, as it is still categorized as a Schedule I drug in the U.S., which makes researching it there very difficult.

However, as we see some more studies and some more definitive results when it comes to the illnessees that cannabis can treat, the growth opportunities could easily exceed the potential that exists in the recreational market. Investors only need to look at the opioid problems south of the border as an example of this.

It may be a longer-term play, but focusing on medical marijuana could provide Aurora with significant growth opportunities over the long term.

Are more acquisitions on the way?

With more and more pot stocks on the exchanges, there’s continually more opportunities for acquisitions. New cannabis companies face big obstacles when it comes to establishing a brand and trying to wrestle away market share from more well-known cannabis companies.

The fragmentation that exists in the industry along with the challenges that small companies face makes it inevitable that we’ll see more acquisitions in the future. Given what we’ve seen so far, I wouldn’t be surprised if Aurora isn’t done.

Bottom line

This latest acquisition by Aurora isn’t going to break its bank or its stock price, and in the long term, a focus on medical marijuana could pay off significantly. Aurora’s share price has struggled since the start of the year, and investors may want to keep this one on their watch list as a further dip in price could make the stock a very appealing buy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Investing

Retirement plan
Dividend Stocks

Planning for Retirement? Here Are the Best Canadian Dividend Stocks to Buy

Buying two of the best Canadian dividend stocks now for the long term can help you retire without financial worries.

Read more »

investment research
Dividend Stocks

A Dividend Giant I’d Buy Over TD Bank Stock

Energy and financials are the TSX’s sector heavyweights, but I’d choose a dividend giant in the former over a big…

Read more »

edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.
Dividend Stocks

2 Dividend Stocks Worth a Permanent Spot in My TFSA

Restaurant Brands International (TSX:QSR) and Berkshire Hathaway (NYSE:BRK.B) are two of my top TFSA holdings that I intend to hold…

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Don’t Avoid Bank Stocks! This 1 Actually Has Massive Long-Term Potential

Some investors have said that it's a good time to avoid bank stocks. Here's one bank you shouldn't avoid. Buy…

Read more »

edit Businessman using calculator next to laptop

5 Stocks You Can Confidently Invest $500 in Right Now

Buy and hold stocks these TSX stocks to outperform the broader market averages in the long term.

Read more »

Increasing yield
Dividend Stocks

3 Canadian Dividend Stocks Offering High Yields and Reliable Income

These valuable dividend stocks offer solid deals right now, with ultra-high yields that will certainly last well beyond this downturn.

Read more »

dividends grow over time
Stocks for Beginners

Passive Income: How I Got to $2,000/Year After Just 4 Years of Saving

I got to $2,000/year in passive income partially by buying bank stocks like Toronto-Dominion Bank (TSX:TD).

Read more »

potted green plant grows up in arrow shape
Dividend Stocks

Best of Both Worlds: 3 Growth Stocks That Also Pay Dividends

Dividend stocks are great until a downturn ends. But luckily, these three dividend stocks also offer a massive amount of…

Read more »